Emerging treatments are rapidly shifting the paradigm of systemic disorders . MOTS-c, along with various molecules, showcase fascinating avenues for treating ailments like type two hyperglycemia and obesity . Although research are ongoing , preliminary results imply substantial improvements in glycemic management and weight loss , sparking consider